LIVIVO - Search results -

Search results

Result 1 - 10 of total 298

Search options

Article: Projet EBO-SURSY : la collaboration multisectorielle et la recherche au service du renforcement des capacités de surveillance épidémiologique des zoonoses en Afrique.

Muset, Sophie / Bourgarel, Mathieu / Tordo, Noël / Delaporte, Éric

2023 Volume 27, Issue S1, Page(s) 3–4

Title translation	EBO-SURSY project: multisectoral collaboration and research to build capacity for epidemiological surveillance of zoonoses in Africa.
MeSH term(s)	Animals ; Capacity Building ; Africa/epidemiology ; Zoonoses/epidemiology ; Zoonoses/prevention & control
Language	French
Publishing date	2023-09-18
Publishing country	France
Document type	Journal Article
ZDB-ID	2118387-9
ISSN	1950-6961 ; 1267-8694
ISSN (online)	1950-6961
ISSN	1267-8694
DOI	10.1684/vir.2023.1010
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article: [No title information]

Etard, Jean-François / Sow, Mamadou Saliou / Kpamou, Cécé / Delaporte, Eric / Touré, Abdoulaye

Revue d'epidemiologie et de sante publique

2023 Volume 71, Issue 5, Page(s) 102143

Title translation	Homogeneous age mixing in Ebola case-contact : A retrospective study in Guinea.
MeSH term(s)	Humans ; Retrospective Studies ; Guinea ; Hemorrhagic Fever, Ebola
Language	French
Publishing date	2023-08-29
Publishing country	France
Document type	Letter
ZDB-ID	199128-0
ISSN	0398-7620
ISSN	0398-7620
DOI	10.1016/j.respe.2023.102143
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Un I Zs.561: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: Comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis.

Taieb, Fabien / Madec, Yoann / Cournil, Amandine / Delaporte, Eric

PloS one

2017 Volume 12, Issue 4, Page(s) e0174767

Abstract: Background: UNAIDS recently defined the 90-90-90 target as a way to end the HIV epidemic. However, the proportion of virological success following antiretroviral therapy (ART) may not be as high as the anticipated 90%, and may in fact be highly ... ...

Abstract	Background: UNAIDS recently defined the 90-90-90 target as a way to end the HIV epidemic. However, the proportion of virological success following antiretroviral therapy (ART) may not be as high as the anticipated 90%, and may in fact be highly heterogeneous. We aimed to describe the proportion of virological success in sub-Saharan Africa and to identify factors associated with the proportion of virological success. Methods: We performed a systematic review and meta-analysis focusing on the proportion of patients in sub-Saharan Africa who demonstrate virological success at 12 and 24 months since ART initiation, as well as at 6 and 36 months, where possible. Programme factors associated with the proportion of virological success were identified using meta-regression. Analyses were conducted using both on-treatment (OT) and intention-to-treat (ITT) approaches. Results: Eighty-five articles were included in the meta-analysis, corresponding to 125 independent study populations. Using an on-treatment approach, the proportions (95% confidence interval (CI)) of virological success at 12 (n = 64) and at 24 (n = 32) months since ART initiation were 87.7% (81.3-91.0) and 83.7% (79.8-87.6), respectively. Univariate analysis indicated that the proportion of virological success was not different by study design. Multivariate analysis at 24 months showed that the proportion of virological success was significantly larger in studies conducted in public sector sites than in other sites (p = 0.045). Using an ITT approach, the proportions (95% CI) of virological success at 12 (n = 50) and at 24 (n = 20) months were 65.4% (61.8-69.1) and 56.8% (51.3-62.4), respectively. At 12 months, multivariate analysis showed that the proportion of success was significantly lower in cohort studies than in trials (63.0% vs. 71.1%; p = 0.017). At 24 months, univariate analysis demonstrated that the proportion of success was also lower in cohorts. Discussion: Regardless of the time following ART initiation, and of the threshold, proportions of virological success were highly variable. Evidence from this review suggests that the new international target of 90% of patients controlled is not yet being achieved, and that in order to improve the virological outcome, efforts should be made to improve retention in care.
MeSH term(s)	Africa South of the Sahara/epidemiology ; Anti-HIV Agents/therapeutic use ; Cohort Studies ; Cross-Sectional Studies ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/virology ; Humans ; Viral Load
Chemical Substances	Anti-HIV Agents
Language	English
Publishing date	2017
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Meta-Analysis ; Review
ISSN	1932-6203
ISSN (online)	1932-6203
DOI	10.1371/journal.pone.0174767
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Exploratory analysis of the knowledge, attitudes and perceptions of healthcare workers about arboviruses in the context of surveillance in the Republic of Guinea.

Bangoura, Salifou Talassone / Hounmenou, Castro Gbêmêmali / Sidibé, Sidikiba / Camara, Saidouba Cherif / Mbaye, Aminata / Olive, Marie-Marie / Camara, Alioune / Delamou, Alexandre / Keita, Alpha-Kabinet / Delaporte, Eric / Khanafer, Nagham / Touré, Abdoulaye

PLoS neglected tropical diseases

2023 Volume 17, Issue 12, Page(s) e0011814

Abstract: Background: The escalating risk and contemporary occurrences of arbovirus infections prompt a critical inquiry into the ability of nations to execute efficient surveillance systems capable to detect, prevent and respond to arbovirus outbreaks. ... ...

Abstract	Background: The escalating risk and contemporary occurrences of arbovirus infections prompt a critical inquiry into the ability of nations to execute efficient surveillance systems capable to detect, prevent and respond to arbovirus outbreaks. Healthcare workers (HCWs) are the major actors in the surveillance of infectious diseases with epidemic potential. The objective of this study was to evaluate the knowledge, attitudes and perceptions of HCWs regarding arboviruses in the public health facilities of Conakry, Guinea. Methods: A cross-sectional survey was conducted during the from December 27, 2022, to January 31, 2023, encompassing from public health facilities in Conakry. The data collection process encompassed various aspects, including the characteristics of health facilities, socio-demographic and professional attributes of HCWs, the information received concerning arboviruses and the sources of information, as well as a series of inquiries designed to evaluate their knowledge, attitudes and perceptions. Subsequently, scores were computed for knowledge, attitude and perception. To identify the factors influencing the knowledge, attitudes, and perceptions of HCWs regarding arboviruses, Decision Tree and Inference Conditional Tree models were used. Results: A total of 352 HCWs participated in the study, comprising 219 from national hospitals, 72 from municipal hospitals and 61 from primary health centers. More than half of the respondents (54.3%) had never received information on arboviruses. Only 1% of the respondents had good knowledge about arboviruses, 95.7% had a negative attitude about arboviruses. Moreover, nearly 60% of the respondents had a moderate perception and 24.1% had a good perception. The analysis revealed significant associations between the knowledge and attitudes of respondents concerning arboviruses and their years of professional experience and age. Conclusion: This study highlights the imperative requirement for comprehensive training targeting HCWs to enhance their capacity for early case detection within healthcare facilities. Additionally, there is a crucial need for analogous studies adopting a mixed-methods approach across all healthcare regions in Guinea.
MeSH term(s)	Humans ; Guinea/epidemiology ; Arboviruses ; Cross-Sectional Studies ; Health Knowledge, Attitudes, Practice ; Health Personnel ; Surveys and Questionnaires
Language	English
Publishing date	2023-12-04
Publishing country	United States
Document type	Journal Article
ZDB-ID	2429704-5
ISSN	1935-2735 ; 1935-2735
ISSN (online)	1935-2735
ISSN	1935-2735
DOI	10.1371/journal.pntd.0011814
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).

Bousmah, Marwân-Al-Qays / Protopopescu, Camelia / Mpoudi-Etame, Mireille / Omgba Bassega, Pierrette / Maradan, Gwenaëlle / Olinga, Justin / Varloteaux, Marie / Tovar-Sanchez, Tamara / Delaporte, Éric / Kouanfack, Charles / Boyer, Sylvie

Journal of acquired immune deficiency syndromes (1999)

2023 Volume 94, Issue 3, Page(s) 262–272

Abstract: Background: We provide new and comprehensive evidence on the evolution of a wide range of patient-reported outcomes (PROs) in the NAMSAL ANRS 12313 trial in Cameroon (2016-2021)-the first randomized comparison of dolutegravir 50 mg (DTG) and low-dose ... ...

Abstract	Background: We provide new and comprehensive evidence on the evolution of a wide range of patient-reported outcomes (PROs) in the NAMSAL ANRS 12313 trial in Cameroon (2016-2021)-the first randomized comparison of dolutegravir 50 mg (DTG) and low-dose efavirenz (ie, 400 mg; EFV400) in treatment-naive adults living with HIV-1 in sub-Saharan Africa. Methods: We first described the evolution of PROs between baseline and week 192. Then, we used random-effects models to measure the effect of time since the initiation of antiretroviral therapy and the differential effect of DTG versus EFV400 on each PRO, adjusting for clinical, demographic, and socioeconomic factors, while accounting for unobserved heterogeneity and missing data. Results: Among the 613 patients randomized (DTG arm, n = 310; EFV400 arm, n = 303), (1) physical and mental health-related quality of life improved by 13.3% and 6.8%, respectively, (2) the percentage of patients with depression, anxiety, and stress decreased from 23.3%, 23.0%, and 7.7% to 3.1%, 3.5%, and 0.4%, respectively, and (3) the mean number of HIV-related symptoms decreased from 7.2 to 3.0 ( P < 0.001). For most PROs, no significant difference was found between both arms, even when accounting for the effect of DTG on weight gain. Nevertheless, our results suggest smaller improvements in mental health outcomes in the DTG arm, with a 5 percentage point higher adjusted probability of having anxiety at week 192 ( P < 0.01). Conclusions: Although supporting the current World Health Organization guidelines recommending DTG-based and EFV400-based regimens as preferred and alternative first-line antiretroviral therapy, further studies should investigate medium-term mental health outcomes in patients on DTG. Trial registration: ClinicalTrials.gov : NCT02777229.
MeSH term(s)	Adult ; Humans ; HIV Infections/drug therapy ; Cameroon ; Quality of Life ; Oxazines/therapeutic use ; Benzoxazines/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Pyridones/therapeutic use ; Patient Reported Outcome Measures ; Anti-HIV Agents/therapeutic use
Chemical Substances	dolutegravir (DKO1W9H7M1) ; efavirenz (JE6H2O27P8) ; Oxazines ; Benzoxazines ; Anti-Retroviral Agents ; Heterocyclic Compounds, 3-Ring ; Pyridones ; Anti-HIV Agents
Language	English
Publishing date	2023-10-09
Publishing country	United States
Document type	Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	645053-2
ISSN	1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
ISSN (online)	1944-7884 ; 1077-9450
ISSN	0897-5965 ; 0894-9255 ; 1525-4135
DOI	10.1097/QAI.0000000000003273
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2442: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Heterogeneity of contact patterns with Ebola virus disease cases.

Etard, Jean-François / Touré, Abdoulaye / Sow, Mamadou Saliou / Subtil, Fabien / Camara, Ibrahima / Kpamou, Cécé / Delaporte, Eric / Ecochard, René

The Journal of infection

2021 Volume 82, Issue 6, Page(s) 276–316

MeSH term(s)	Disease Outbreaks ; Ebolavirus ; Hemorrhagic Fever, Ebola/epidemiology ; Humans
Language	English
Publishing date	2021-03-18
Publishing country	England
Document type	Letter ; Research Support, Non-U.S. Gov't ; Comment
ZDB-ID	424417-5
ISSN	1532-2742 ; 0163-4453
ISSN (online)	1532-2742
ISSN	0163-4453
DOI	10.1016/j.jinf.2021.03.009
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1501: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 48: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Reply.

Hereth Hébert, Esther / Resnikoff, Serge / March, Laura / Delaporte, Eric

American journal of ophthalmology

2017 Volume 181, Page(s) 180

MeSH term(s)	Disease Outbreaks ; Eye ; Guinea ; Hemorrhagic Fever, Ebola ; Humans ; Survivors
Language	English
Publishing date	2017-07-31
Publishing country	United States
Document type	Letter ; Comment
ZDB-ID	80030-2
ISSN	1879-1891 ; 0002-9394
ISSN (online)	1879-1891
ISSN	0002-9394
DOI	10.1016/j.ajo.2017.06.032
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ul I Zs.39: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Interest of seroprevalence surveys for the epidemiological surveillance of the SARS-CoV-2 pandemic in African populations: Insights from the ARIACOV project in Benin.

Houngbégnon, Parfait / Nouatin, Odilon / Yadouléton, Anges / Hounkpatin, Benjamin / Fievet, Nadine / Atindégla, Eloïc / Dechavanne, Sébastien / Guichet, Emilande / Ayouba, Ahidjo / Pelloquin, Raphaël / Maman, David / Thaurignac, Guillaume / Peeters, Martine / Aviansou, Annonciat / Sourakafou, Salifou / Delaporte, Eric / Massougbodji, Achille / Cottrell, Gilles

Tropical medicine & international health : TM & IH

2023 Volume 28, Issue 7, Page(s) 508–516

Abstract: Background: Many SARS-CoV-2 seroprevalence surveys since the end of 2020 have disqualified the first misconception that Africa had been spared by the pandemic. Through the analysis of three SARS-CoV-2 seroprevalence surveys carried out in Benin as part ... ...

Abstract	Background: Many SARS-CoV-2 seroprevalence surveys since the end of 2020 have disqualified the first misconception that Africa had been spared by the pandemic. Through the analysis of three SARS-CoV-2 seroprevalence surveys carried out in Benin as part of the ARIACOV project, we argue that the integration of epidemiological serosurveillance of the SARS-CoV-2 infection in the national surveillance packages would be of great use to refine the understanding of the COVID-19 pandemic in Africa. Methods: We carried out three repeated cross-sectional surveys in Benin: two in Cotonou, the economic capital in March and May 2021, and one in Natitingou, a semi-rural city in the north of the country in August 2021. Total and weighted-by-age-group seroprevalences were estimated and the risk factors for SARS-CoV-2 infection were assessed by multivariate logistic regression. Results: In Cotonou, a slight increase in overall age-standardised SARS-CoV-2 seroprevalence from 29.77% (95% CI: 23.12%-37.41%) at the first survey to 34.86% (95% CI: 31.57%-38.30%) at the second survey was observed. In Natitingou, the globally adjusted seroprevalence was 33.34% (95% CI: 27.75%-39.44%). A trend of high risk for SARS-CoV 2 seropositivity was observed in adults over 40 versus the young (less than 18 years old) during the first survey in Cotonou but no longer in the second survey. Conclusions: Our results show that, however, rapid organisation of preventive measures aimed at breaking the chains of transmission, they were ultimately unable to prevent a wide spread of the virus in the population. Routine serological surveillance on strategic sentinel sites and/or populations could constitute a cost-effective compromise to better anticipate the onset of new waves and define public health strategies.
MeSH term(s)	Humans ; Adolescent ; SARS-CoV-2 ; Benin/epidemiology ; COVID-19/epidemiology ; Pandemics ; Cross-Sectional Studies ; Seroepidemiologic Studies ; Antibodies, Viral
Chemical Substances	Antibodies, Viral
Language	English
Publishing date	2023-05-27
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	1314080-2
ISSN	1365-3156 ; 1360-2276
ISSN (online)	1365-3156
ISSN	1360-2276
DOI	10.1111/tmi.13895
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4415: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.

Tovar Sanchez, Tamara / Mpoudi-Etame, Mireille / Kouanfack, Charles / Delaporte, Eric / Calmy, Alexandra / Venter, Francois / Sokhela, Simiso / Bosch, Bronwyn / Akpomiemie, Godspower / Tembo, Angela / Pepperrell, Toby / Simmons, Bryony / Casas, Carmen Perez / McCann, Kaitlyn / Mirchandani, Manya / Hill, Andrew

Frontiers in reproductive health

2023 Volume 5, Page(s) 1133556

Abstract: Introduction: The ADVANCE and NAMSAL trials evaluating antiretroviral drugs have both reported substantial levels of clinical obesity in participants. As one of the main risk factors for metabolic syndrome, growing rates of obesity may drive metabolic ... ...

Abstract	Introduction: The ADVANCE and NAMSAL trials evaluating antiretroviral drugs have both reported substantial levels of clinical obesity in participants. As one of the main risk factors for metabolic syndrome, growing rates of obesity may drive metabolic syndrome development. This study aims to evaluate the risk of metabolic syndrome in the ADVANCE and NAMSAL trials. Methods: The number of participants with metabolic syndrome was calculated at baseline and week 192 as central obesity and any of the following two factors: raised triglycerides, reduced HDL-cholesterol, raised blood pressure and raised fasting glucose. Differences between the treatment arms were calculated using the Results: Across all visits to week 192, treatment-emergent metabolic syndrome was 15% (TAF/FTC + DTG), 10% (TDF/FTC + DTG) and 7% (TDF/FTC/EFV) in ADVANCE. The results were significantly higher in the TAF/FTC + DTG arm compared to the TDF/FTC/EFV arm ( Conclusion: In this analysis, we highlight treatment-emergent metabolic syndrome associated with dolutegravir, likely driven by obesity. Clinicians initiating or monitoring patients on INSTI-based ART must counsel for lifestyle optimisation to prevent these effects.
Language	English
Publishing date	2023-09-18
Publishing country	Switzerland
Document type	Journal Article
ISSN	2673-3153
ISSN (online)	2673-3153
DOI	10.3389/frph.2023.1133556
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: High Seroprevalence of IgG Antibodies to Multiple Arboviruses in People Living with HIV (PLWHIV) in Madagascar.

Rakotomalala, Fetra Angelot / Bouillin, Julie / Randriarimanana, Santatriniaina Dauphin / Thaurignac, Guillaume / Maharavo, Luca / Raberahona, Mihaja / Razafindrakoto, Lucien / Rasoanarivo, Jasmina / Rakoto-Andrianarivelo, Mala / Rakoto, Danielle Aurore Doll / Babin, François Xavier / Rasamoelina, Tahinamandranto / Delaporte, Eric / Samison, Luc Hervé / Peeters, Martine / Nerrienet, Eric / Ayouba, Ahidjo

Viruses

2023 Volume 15, Issue 11

Abstract: To estimate the prevalence of IgG antibodies against six arboviruses in people living with HIV-1 (PLWHIV) in Madagascar, we tested samples collected between January 2018 and June 2021. We used a Luminex-based serological assay to detect IgG antibodies ... ...

Abstract	To estimate the prevalence of IgG antibodies against six arboviruses in people living with HIV-1 (PLWHIV) in Madagascar, we tested samples collected between January 2018 and June 2021. We used a Luminex-based serological assay to detect IgG antibodies against antigens from Dengue virus serotypes 1-4 (DENV1-4), Zika virus (ZIKV), West Nile virus (WNV), Usutu virus (USUV), Chikungunya virus (CHIKV), and O'nyong nyong virus (ONNV). Of the 1036 samples tested, IgG antibody prevalence was highest for ONNV (28.4%), CHIKV (26.7%), WNV-NS1 (27.1%), DENV1 (12.4%), USUV (9.9%), and DENV3 (8.9%). ZIKV (4.9%), DENV2 (4.6%), WNV-D3 (5.1%), and DENV4 (1.4%) were lower. These rates varied by province of origin, with the highest rates observed in Toamasina, on the eastern coast (50.5% and 56.8%, for CHIKV and ONNV, respectively). The seroprevalence increased with age for DENV1 and 3 (
MeSH term(s)	Humans ; Arboviruses ; Zika Virus Infection/diagnosis ; Madagascar/epidemiology ; Immunoglobulin G ; Seroepidemiologic Studies ; Zika Virus ; Chikungunya virus ; West Nile virus ; HIV Infections/complications ; HIV Infections/epidemiology ; Antibodies, Viral ; Chikungunya Fever
Chemical Substances	Immunoglobulin G ; Antibodies, Viral
Language	English
Publishing date	2023-11-15
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2516098-9
ISSN	1999-4915 ; 1999-4915
ISSN (online)	1999-4915
ISSN	1999-4915
DOI	10.3390/v15112258
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito